Ownership and insider activity for Teleflex Incorporated (TFX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide.
Price
| Price | $125.24 |
| Market Cap | $5.5B |
| Exchange | NYSE |
| Country | US |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $543.8M | $333.6M | $357.2M | $301.1M | $375.9M | $445.1M | $292.0M | $222.8M | $290.2M | $393.3M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $16.0M | 0 |
| Receivables | $272.0M | $345.9M | $366.3M | $418.7M | $395.1M | $383.6M | $408.8M | $443.5M | $459.5M | $345.6M |
| Inventory | $316.2M | $395.7M | $427.8M | $476.6M | $513.2M | $477.6M | $578.5M | $626.2M | $600.1M | $404.4M |
| Total Current Assets | $1.18B | $1.13B | $1.24B | $1.31B | $1.42B | $1.43B | $1.41B | $1.41B | $1.47B | $1.94B |
| Property, Plant & Equipment | $302.9M | $383.0M | $432.8M | $543.9M | $574.5M | $573.4M | $578.4M | $603.4M | $611.8M | $590.1M |
| Goodwill | $1.28B | $2.24B | $2.25B | $2.25B | $2.59B | $2.50B | $2.54B | $2.91B | $2.63B | $2.31B |
| Intangible Assets | $1.09B | $2.38B | $2.33B | $2.16B | $2.52B | $2.29B | $2.31B | $2.50B | $2.27B | $1.52B |
| Total Assets | $3.89B | $6.18B | $6.28B | $6.31B | $7.15B | $6.87B | $6.93B | $7.53B | $7.10B | $6.95B |
| Accounts Payable | $69.4M | $92.0M | $106.7M | $102.9M | $102.5M | $118.2M | $126.8M | $132.2M | $141.0M | $130.2M |
| Short-term Debt | $183.1M | $86.6M | $86.6M | $50.0M | $100.5M | $110.0M | $87.5M | $87.5M | $100.0M | $100.0M |
| Total Current Liabilities | $427.6M | $483.9M | $582.5M | $563.1M | $540.0M | $680.1M | $581.5M | $606.7M | $649.4M | $762.0M |
| Long-term Debt | $850.3M | $2.16B | $2.07B | $1.86B | $2.38B | $1.74B | $1.62B | $1.73B | $1.56B | $2.54B |
| Total Liabilities | $1.75B | $3.75B | $3.74B | $3.33B | $3.82B | $3.12B | $2.91B | $3.09B | $2.82B | $3.82B |
| Retained Earnings | $2.19B | $2.29B | $2.43B | $2.82B | $3.10B | $3.52B | $3.82B | $4.11B | $4.12B | $3.15B |
| Total Equity | $2.14B | $2.43B | $2.54B | $2.98B | $3.34B | $3.75B | $4.02B | $4.44B | $4.28B | $3.12B |
| Total Debt | $1.03B | $2.25B | $2.16B | $2.01B | $2.56B | $1.97B | $1.83B | $1.93B | $1.76B | $2.73B |
| Net Debt | $489.5M | $1.92B | $1.80B | $1.71B | $2.19B | $1.52B | $1.54B | $1.70B | $1.45B | $2.33B |
| Working Capital | $755.7M | $644.9M | $653.7M | $743.3M | $882.4M | $749.0M | $829.5M | $800.7M | $821.8M | $1.18B |
Financial Health
| Debt / Equity | 0.99 |
| Current Ratio | 2.60 |
Profitability
| Return on Equity | -31.83% |
| Return on Invested Capital | 1.30% |
| Return on Assets | -15.17% |
| Gross Margin | 53.77% |
| Operating Margin | 3.35% |
| Net Margin | -39.58% |
Related companies: ALKS · ARWR · BLCO · CRSP · KRYS · MMSI · PCVX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of TFX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks